Sanofi has appointed Diane Souza and Thomas Südhof to its board of directors as independent directors, effective 4 May.
Souza brings over 25 years of managed care and health benefits expertise as well as financial management experience to the board. She most recently served as chief executive officer of UnitedHealthcare Speciality Benefits, a voluntary health insurance business.
Prior to this, Souza held the role of chief financial officer at Aetna, overseeing its guaranteed products business, and has also held senior leadership positions at Deloitte and PriceWaterhouseCooper.
Meanwhile, Südhof currently serves as the Avram Goldstein professor and professor of molecular and cellular physiology, psychiatry and neurology at Stanford University’s school of medicine.
Before joining Stanford, he spent 25 years at the University of Texas as chairman of the department of neuroscience researching neuro-degenerative and neuro-psychiatric diseases. Südhof was a member of team who won the Nobel Prize in physiology or medicine in 2013.
Serge Weinberg, chairman of Sanofi’s board, said: “Both Diane Souza and Thomas Südhof are noted health experts and their great skills make them an outstanding addition to our board.
“We look forward to their contribution to Sanofi’s strategy as we continue to innovate and introduce new medicines and vaccines that can help improve health outcomes.”